Status:
TERMINATED
Electrophysiological Biomarkers in MTLE Patients.
Lead Sponsor:
Emory University
Conditions:
Mesial Temporal Lobe Epilepsy
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The investigators plan to enroll individuals with medical temporal lobe epilepsy who are undergoing surgical workup with clinically implanted intracranial electrodes. The study intends to administer c...
Detailed Description
This is a nonrandomized interventional trial that will apply brain stimulation via clinically implanted intracranial electrodes to subjects with medial temporal lobe epilepsy with the purpose of ident...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Provision of signed and dated informed consent form
- Male or female, aged 18-65
- Diagnosed with lesional or non-lesional mesial temporal (hippocampal) seizure onset confirmed on SEEG monitoring
- Implanted with depth electrodes for localization of seizure onset with multiple hippocampal electrode arrays
- Exclusion criteria:
- Any patient who is unwilling or unable to provide consent
- Women who are pregnant
- Patients under 18 years
- Incarcerated persons
Exclusion
Key Trial Info
Start Date :
November 30 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 16 2021
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT04710004
Start Date
November 30 2021
End Date
December 16 2021
Last Update
March 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Epilepsy monitoring unit (EMU) at Emory University Hospital
Atlanta, Georgia, United States, 30322